快樂小藥師
本部落格為介紹醫藥相關知識部落格,並沒有販賣藥品。此外文章部分內容可能會引起您的不安或是心理不適,在按下繼續閱讀前,請先自我評估,謝謝(原創文章如需轉載請先告知 左右水平廣告輪播-語法
  • // 如果你希望圖片繼續多一點,那就自己再複製增加

目前分類:FDA 公告 (120)

瀏覽方式: 標題列表 簡短摘要

OxyContin-addiction-statistics2  

The US Food and Drug Administration (FDA) today approved updated labelling for the abuse-deterrent formulation of oxycodone hydrochloride controlled-release tablets (OxyContin, Purdue Pharma LP).

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

logo-diclegis-header  

The US Food and Drug Administration (FDA) today approved the combination of doxylamine and pyridoxine (Diclegis, Duchesnay) to treat pregnant women with nausea and vomiting who have not adequately responded to dietary and lifestyle changes, the agency has announced.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

cataract  

Today the Food and Drug Administration (FDA) approved a new formulation of a once-daily nonsteroidal anti-inflammatory drug (NSAID) for the treatment of postoperative pain and inflammation in patients who have undergone cataract surgery. The newly approved 0.7% bromfenac ophthalmic solution (Prolensa, Bausch + Lomb) will likely replace the currently available 0.9% bromfenac ophthalmic solution.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

220px-Carbinoxamine.svg  

The US Food and Drug Administration (FDA) has approved carbinoxamine maleate extended-release (Karbinal ER, Tris Pharma), the first liquid, sustained-release histamine-H1 receptor blocker indicated for the treatment of seasonal and perennial allergic rhinitis in children aged 2 years and older, the company said.
The drug will be available in a 4 mg/5 mL oral suspension.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

011169596  

The US Food and Drug Administration (FDA) has approved long-acting aripiprazole (Abilify Maintena, Otsuka/Lundbeck) for the maintenance treatment of adults with schizophrenia.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

289319  

FDA核准Osphena使用在中度至重度的停經後的性交疼痛

The US Food and Drug Administration (FDA) has approved ospemifene (Osphena, Shionogi, Inc) for treating moderate to severe dyspareunia in postmenopausal women, the agencyannounced today.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

regorafenib-product  

The indication for the oral targeted agent regorafenib (Stivarga, Bayer) has been expanded by the US Food and Drug Administration (FDA); it is now approved for the treatment of gastrointestinal stromal tumors (GIST). Specifically, it is indicated for use in patients with tumors that cannot be surgically removed and no longer respond to imatinib (Gleevec) and sunitinib (Sutent), the 2 other FDA-approved treatments for this disease.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

Uceris  

The US Food and Drug Administration (FDA) has approved budesonide extended release tablets (Uceris, Santarus) for the treatment of active mild to moderate ulcerative colitis in adult patients, the manufacturer announced January 16.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

7939626.bin  

The oral therapy pomalidomide (Pomalyst, Celgene) was approved by the US Food and Drug Administration today for use in the treatment of multiple myeloma.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

Oxytrol  

The FDA has approved Oxytrol for Women, the first over-the-counter treatment for overactive bladder in women 18 and older.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

608px-Alogliptin.svg  

The US Food and Drug Administration has approved 3 different formulations of the selective dipeptidyl peptidase IV inhibitor alogliptin for the treatment of type 2 diabetes.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

adasuve  

The US Food and Drug Administration (FDA) has approved loxapine ( Adasuve , Alexza Pharmaceuticals) inhalation powder 10 mg for the acute treatment of agitation associated with schizophrenia or bipolar I disorder in adults.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

varizig_vial  

The US Food and Drug Administration (FDA) today approved the varicella immune globulin preparation Varizig (Cangene) for reducing the severity of chickenpox infections in high-risk individuals when given within 4 days after exposure.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

200px-Bedaquiline.svg  

The US Food and Drug Administration (FDA) approved bedaquiline today as part of the treatment regimen for multidrug-resistant tuberculosis (MDR-TB) when other agents are unavailable.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

Eliquis    

The US Food and Drug Administration (FDA) has approved apixaban (Eliquis, Bristol-Myers Squibb/Pfizer) for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation (AF).

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

perampanel  

The US Food and Drug Administration (FDA) today announced approval of perampanel tablets (Fycompa, Eisai Inc) for treatment of partial-onset seizures in patients with epilepsy 12 years of age and older.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

ocriplasmin1  

The US Food and Drug Administration (FDA) yesterday approved ocriplasmin intravitreal injection (Jetrea, ThromboGenics, Inc) for the treatment of symptomatic vitreomacular adhesions (VMAs), the agency announced today.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

humira  

The US Food and Drug Administration (FDA) today approved adalimumab (Humira, Abbott Laboratories) for its seventh use: treating ulcerative colitis.

Adalimumab is now indicated for moderate to severe ulcerative colitis in adults who have not been helped by corticosteroids and other immunosuppressant medicines, the FDA stated in a press release today.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

120927053554-stivarga-packaging-story-top  

The US Food and Drug Administration (FDA) has approved the oral therapy regorafenib (Stivarga, Bayer) for the treatment of metastatic colorectal cancer.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

375px-Linaclotide.svg  

美國藥檢局核准新藥Linaclotide膠囊 (145ug) 上市,應用在原發性慢性便秘,以及大腸急躁症 (IBS) 合併便秘症。

The US Food and Drug Administration (FDA) approved the drug linaclotide (Linzess, Ironwood Pharmaceuticals) today for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C) in adults.

文章標籤

快樂小藥師 發表在 痞客邦 留言(0) 人氣()

Close

您尚未登入,將以訪客身份留言。亦可以上方服務帳號登入留言

請輸入暱稱 ( 最多顯示 6 個中文字元 )

請輸入標題 ( 最多顯示 9 個中文字元 )

請輸入內容 ( 最多 140 個中文字元 )

reload

請輸入左方認證碼:

看不懂,換張圖

請輸入驗證碼